Member Info for lordloadsoflolly

Here we go again - lambo222 sewing seeds of doubt with his "I really do hope the bod don’t do a placing atm".

Knees bent, arms stretched, ra ra ra

IQE will NEVER be anything like another ARM. 1) Its margins are a fraction of ARM's. 2) It doesn't use a licensing model 3) It's a manufacturer, whilst ARM isn't.

Alwaysone - it was, provided you then sold - to bank a quick profit. If you didn't, only time will tell whether it was such a good move.

You carry on wondering that chumba. And maybe come back in 2 or 3 years to see if your theory still holds.

Gotrader - I think you'll find HSBC NEVER wanted to pull their overdraft, as that could well have led to IQE's insolvency, putting the bank's money at risk. No, HSBC is far too clever for that. Instead, they made it a condition of continued support that a rapid placing happened. Overnight, this improved the company's liquidity - to the extent that HSBC's overdraft money is at lower risk of default. As always, a win win for the bankers.

Tambo210 - I won't keep responding to your comments after this post, as we're in danger of becoming repetitive. A lot of your observations re: inflation and interest rates are from a largely UK perspective. And I agree with many of them.

Of course there are major differences here between the 80s & today. But there was consumer exuberance at times in the 80s too (remember the Yuppies?!) Regardless, SMT is far less impacted by what happens in the UK than the US or China. And in both these countries, inflation has already started falling significantly. Sure, the US may still impose one or two more interest rate rises and opinions amongst FED members may vary. But if inflation continues its mostly downward trajectory (as US economists generally now expect), they won't need to do more than that. And since markets try to look forward, share prices should increasingly start pricing this in.

You're right that central banks can't control wage inflation. That's the job of governments, at least when it comes to the public sector. And in the UK they're doing just that. The vast majority of settlements so far have been way below inflation. And I don't see the UK government granting junior doctors/train workers etc. anything like the percentages they're asking for. Or being in a tearing hurry to bring these strikes to an end (cynically, they may still think there's plenty of time before the next general election!). This will just become a war of attrition until staff see how much they've already lost through strike days & decide to reach some sort of mutually acceptable compromise. A similar trend is playing out in the US, where wage settlements have fallen well below last year's peaks (although they're currently still above the current falling inflation rate): hTTps://tradingeconomics.com/united-states/wage-growth#:~:text=Wage%20Growth%20in%20the%20United,percent%20in%20March%20of%202009

Falling inflation coupled with no-longer-rising interest rates will eventually have a positive impact on the stock market. And in particular growth stocks, where SMT concentrates.

Oscar22 - ROFL. That's all.

Well there's a vote of confidence from wildtiger then.

Tambo210 - you & I clearly have a very different interpretation of things. Of course, with hindsight, SMT shouldn't have bought MRNA at or above $200. That, however, doesn't mean $50 is on the cards for Moderna. Just as there are many ways to skin a cat, there are many ways to value a company. Of which PBV/cash on hand are just two tools - better suited to some business models than others. It soubnds lkike you may have missed it, but the FED recently signalled a pause/halt in further rate rises: hTTps://www.reuters.com/markets/us/fed-likely-hike-rates-hint-pause-tightening-cycle-2023-05-03/. And to suggest that they &/or the BOE are deliberately trying to crash the economy is just plain nuts. But each to their own.

Only reason to be pleasantly surprised is if you weren't already a holder. Or if some mind-altering substance/too many sherbets got the better of you.

Basscadet - pleasantly surprised? What are you on mate?

Tambo210 - I'd question two of your assumptions. 1) MRNA falling to $50 or under. Anyone's guess & certainly possible (as is any forecast, ultimately!). But highly unlikely IMHO. 2) UK inflation hasn't followed the rapid downward trajectory of most other developed economies so far. But UK inflation also isn't that relevant to SMT. Take a look at the FT chart for countries like the US, which are far more significant in terms of their impact on SMT's holdings: hTTps://www.ft.com/content/088d3368-bb8b-4ff3-9df7-a7680d4d81b2

Oscar22 - 'fraid I only got as far as this part of your post before I fell off my chair laughing: "ImmuPharma PLC, a distinguished name in the realm of drug discovery and development"

Microsalt's RNS re: Jack Stein becoming a brand ambassador sounds sensible. But TEK's share price hasn't budged on the back of it. Whereas news of Microsalt teaming up with a MAJOR fast food retailer or ready meal producer might just move the dial. But for now, no news on that front. Unless you count Presty. Which I don't.

Enough politics - & back to SMT!

Rather than rely on the FT's summary, I'd suggest reading Scottish Mortgage's Final Results RNS in full, if you've time: hTTps://www.lse.co.uk/rns/SMT/scottish-mortgage-inv-trst-final-results-ihzyt0ojb7syde5.html

At least the dividend payout is up 14.2%. Though of course this does very little to offset SMT's sharp share price drop since late 2021. But a bird in the hand and all that!

Erm, having no cash would be a fairly major business risk lambo! Interesting that commencement of the Phase2/3 trial is: "defined as the CRO is chosen, trial sites are being confirmed and set-up and regulatory and ethics committee submissions are progressing". As we already knew, this is still VERY early days & a real long shot (though potentially transformative for IMM still)

Lambo222 - "buy at 2.6 and sell to others much higher". So the question now is, how much higher before we suddenly see lambo222 posting about all the negatives & risks inherent in holding IMM?

You put your right arm in

Your right arm out

In, out, in, out

You shake it all about

Apeirogon - I guess the only scenario would be if they felt Opti had a superior formulation with watertight patent protection.

Sorry - you’re right. I should have known, as I’d already posted about 18th May several times! To recap, HAT goes ex div on 18th May, so tomorrow (Wednesday 17th) is the last day to buy if you wish to qualify for 23 June’s 10p a share payout.

An interesting RNS announced after yesterday's close for H&T's new performance-related share option scheme: hTTps://otp.tools.investis.com/clients/uk/harvey-and-thompson/rns/regulatory-story.aspx?cid=135&newsid=1687750. The way I read it, qualifying senior management don't have to pay for their options, providing they achieve set targets. If so, that to me is ridiculous. Surely they should STILL have to pay (even if at a lower-than-current-market price)? That said, the targets to qualify look fairly ambitious, with a MINIMUM 106% increase in EPS by 31 December 2025. If they achieve even that, there should be a substantial upward share price re-rate by then. Not to mention a significant boost to dividend payouts. I topped up further, both yesterday & today, on the share price weakness, as I can't see any obvious reason for it. Ex dividend tomorrow, so thought I'd get in beforehand to qualify for the 23 June 10p a share payout. The price could well drift lower still (particularly tomorrow when it goes ex-div). But on a 12 month+ view, I'm reasonably confident these latest buys will prove sound. H&T is now my 2nd largest holding.